Related references
Note: Only part of the references are listed.Benefits, toxicity and current market of cannabidiol in edibles
Gonzalo Astray et al.
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2023)
Observed Impact of Long-term Consumption of Oral Cannabidiol on Liver Function in Healthy Adults
Robert Kaufmann et al.
CANNABIS AND CANNABINOID RESEARCH (2023)
Adipose Tissue Inflammation and Cardiovascular Disease: An Update
Mariam N. Rana et al.
CURRENT DIABETES REPORTS (2022)
Impact of excipient emulsions made from different types of oils on the bioavailability and metabolism of curcumin in gastrointestinal tract
Haiyan Luo et al.
FOOD CHEMISTRY (2022)
Cannabidiol and Abnormal Liver Chemistries in Healthy Adults: Results of a Phase I Clinical Trial
Paul B. Watkins et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
The current understanding of the benefits, safety, and regulation of cannabidiol in consumer products
Jinpeng Li et al.
FOOD AND CHEMICAL TOXICOLOGY (2021)
What Role Does the Endocannabinoid System Play in the Pathogenesis of Obesity?
Piotr Schulz et al.
NUTRIENTS (2021)
Lipid-based formulations to increase cannabidiol bioavailability: In vitro digestion tests, pre-clinical assessment and clinical trial
Manuel A. A. De Pra et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2021)
Phytocannabinoids-A Green Approach toward Non-Alcoholic Fatty Liver Disease Treatment
Klaudia Berk et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Comparison of Five Oral Cannabidiol Preparations in Adult Humans: Pharmacokinetics, Body Composition, and Heart Rate Variability
Natasha N. Bondareva Williams et al.
PHARMACEUTICALS (2021)
Pharmacokinetic Investigation of Commercially Available Edible Marijuana Products in Humans: Potential Influence of Body Composition and Influence on Glucose Control
Taylor Russell Ewell et al.
PHARMACEUTICALS (2021)
COVID-19 and Obesity: Overlapping of Two Pandemics
Maria Alessandra Gammone et al.
OBESITY FACTS (2021)
A phase 1, randomized, pharmacokinetic trial of the effect of different meal compositions, whole milk, and alcohol on cannabidiol exposure and safety in healthy subjects
Julie Crockett et al.
EPILEPSIA (2020)
The effect of medium chain and long chain triglycerides incorporated in selfnano emulsifying drug delivery systems on oral absorption of cannabinoids in rats
Dvora Izgelov et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
Antioxidative and Anti-Inflammatory Properties of Cannabidiol
Sinemyiz Atalay et al.
ANTIOXIDANTS (2020)
Dose-Ranging Effect of Adjunctive Oral Cannabidiol vs Placebo on Convulsive Seizure Frequency in Dravet Syndrome A Randomized Clinical Trial
Ian Miller et al.
JAMA NEUROLOGY (2020)
Phytocannabinoids: Useful Drugs for the Treatment of Obesity? Special Focus on Cannabidiol
Patrycja Bielawiec et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Evaluation of pharmacokinetics and acute anti-inflammatory potential of two oral cannabidiol preparations in healthy adults
Jack M. Hobbs et al.
PHYTOTHERAPY RESEARCH (2020)
The Interplay Between Liver First-Pass Effect and Lymphatic Absorption of Cannabidiol and Its Implications for Cannabidiol Oral Formulations
Valentina Franco et al.
CLINICAL PHARMACOKINETICS (2020)
Pharmacokinetic investigation of synthetic cannabidiol oral formulations in healthy volunteers
Dvora Izgelov et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2020)
Lower Postprandial Thermogenic Response to an Unprocessed Whole Food Meal Compared to an Iso-Energetic/Macronutrient Meal Replacement in Young Women: A Single-Blind Randomized Cross-Over Trial
Alex E. Mohr et al.
NUTRIENTS (2020)
Chronic Cannabidiol Administration Attenuates Skeletal Muscle De Novo Ceramide Synthesis Pathway and Related Metabolic Effects in a Rat Model of High-Fat Diet-Induced Obesity
Patrycja Bielawiec et al.
BIOMOLECULES (2020)
Therapeutic Efficacy of Cannabidiol (CBD): a Review of the Evidence From Clinical Trials and Human Laboratory Studies
Dennis J. Sholler et al.
CURRENT ADDICTION REPORTS (2020)
Lack of evidence for the effectiveness or safety of over-the-counter cannabidiol products
Edward Chesney et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2020)
The Thermic Effect of Food: A Review
Manuel Calcagno et al.
JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION (2019)
Use of sorbitol as pharmaceutical excipient in the present day formulations - issues and challenges for drug absorption and bioavailability
Ranjeet Prasad Dash et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2019)
Chokeberry polyphenols preservation using spray drying: effect of encapsulation using maltodextrin and skimmed milk on their recovery following in vitro digestion
Nada Cujic-Nikolic et al.
JOURNAL OF MICROENCAPSULATION (2019)
A Novel Self-Emulsifying Drug Delivery System (SEDDS) Based on VESIsorb® Formulation Technology Improving the Oral Bioavailability of Cannabidiol in Healthy Subjects
Katharina Knaub et al.
MOLECULES (2019)
Cannabidiol improves metabolic dysfunction in middle-aged diabetic rats submitted to a chronic cerebral hypoperfusion
Maria Rosa Trentin Zorzenon et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2019)
Influence of Sodium Glucose Cotransporter 2 Inhibition on Physiological Adaptation to Endurance Exercise Training
Alissa A. Newman et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Metabolic adaptation and maladaptation in adipose tissue
Edward T. Chouchani et al.
NATURE METABOLISM (2019)
Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial
Elizabeth A. Thiele et al.
LANCET (2018)
Effect of Cannabidiol on Drop Seizures in the Lennox-Gastaut Syndrome
Orrin Devinsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Cannabis in liver disorders: a friend or a foe?
Hemant Goyal et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2018)
Cannabinoid Delivery Systems for Pain and Inflammation Treatment
Natascia Bruni et al.
MOLECULES (2018)
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects
Lesley Taylor et al.
CNS DRUGS (2018)
A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans
Sophie A. Millar et al.
FRONTIERS IN PHARMACOLOGY (2018)
Lipopolysaccharide Alters Thermogenic and Inflammatory Genes in White Adipose Tissue in Mice Fed Diets with Distinct 18-Carbon Fatty-Acid Composition
Sunhye Shin et al.
LIPIDS (2018)
Food, gastrointestinal pH, and models of oral drug absorption
Ahmad Y. Abuhelwa et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2017)
Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults
Majid Ezzati et al.
LANCET (2017)
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
Orrin Devinsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Role of the endocannabinoid system in diabetes and diabetic complications
G. Gruden et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study
Khalid A. Jadoon et al.
DIABETES CARE (2016)
Rapid Rehydration and Moderate Plasma Glucose Elevation by Fluid Containing Enzymatically Synthesized Glycogen
Kei Inagaki et al.
JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY (2011)
Influence of Short-Term Consumption of the Caffeine-Free, Epigallocatechin-3-Gallate Supplement, Teavigo, on Resting Metabolism and the Thermic Effect of Feeding
Mark C. Lonac et al.
OBESITY (2011)
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Delta(9)-tetrahydrocannabinol, cannabidiol and Delta(9)-tetrahydrocannabivarin
R. G. Pertwee
BRITISH JOURNAL OF PHARMACOLOGY (2008)
The endocannabinoid system in obesity and type 2 diabetes
V. Di Marzo
DIABETOLOGIA (2008)
Influence of ascorbic acid on the thermic effect of feeding in overweight and obese adult humans
Sean A. Newsom et al.
OBESITY (2008)
Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro
A. Thomas et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Thermic effect of food and β-adrenergic thermogenic responsiveness in habitually exercising and sedentary healthy adult humans
Nicole R. Stob et al.
JOURNAL OF APPLIED PHYSIOLOGY (2007)
Thermogenic responsiveness to β-adrenergic stimulation is augmented in exercising versus sedentary adults:: role of oxidative stress
C Bell et al.
JOURNAL OF PHYSIOLOGY-LONDON (2006)
Endocannabinoids and liver disease - review
E Gabbay et al.
LIVER INTERNATIONAL (2005)
Role of sympathetic neural activation in age- and habitual exercise-related differences in the thermic effect of food
PP Jones et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
The thermic effect of food and obesity: Discrepant results and methodological variations
GP Granata et al.
NUTRITION REVIEWS (2002)
Share Paper
